MUKKA PROTEINS IPO GMP
Dindigul Farm Product IPO allotment expected soon as GMP indicates multibagger listing. Here's how you can check status
Dindigul Farm Products IPO, with robust demand and impressive subscription numbers, is poised for a successful listing. The company's focus on dairy processing aligns with India's leading position in milk production, showcasing a promising future.
Dindigul Farm Product IPO opens today: Check issue size, price band, GMP and other details
Dindigul Farm Product SME IPO offers 64 lakh shares at Rs 51-54 each, aiming to raise Rs 35 crore and list on BSE SME platform.
Nepalese billionaire who made his fortune making instant noodles aims to list India unit by 2026
The listing plans for the firm, which has a 28% share in the local instant noodles market and an annual revenue of 8 billion rupees ($96.2 million), are still in the early stages of discussion, he added. It aims to grow its revenue by 15% this year.
$17.7 billion worth of shares to enter market in next 3 months as IPO lock-in expires for 66 cos
The value pertains to the total lock-up opening shares and it is important to note that not all of these shares will come for sale as a sizable portion of these shares are also held by promoters and groups.
JG Chemicals IPO subscribed 27 times over 3-day period. Check GMP and other details
JG Chemicals IPO GMP: The issue received over 22.69 crore consolidated share bids against 8,168,714 shares available for subscription. The retail portion of the issue was subscribed 17.43 times while the non-institutional category (NII) category was subscribed 46.32 times.
Mukka Proteins debuts with 57% premium over IPO price
Mukka Proteins Share Price: Mukka Proteins' shares debut with a 57% premium. The IPO received strong subscription. The company sells fish meal domestically and exports to multiple countries. It has a significant market share in India and recorded impressive revenue and profit growth.
- Go To Page 1
Mukka Proteins lists at 57% premium over IPO price; should you hold or sell for listing gains?
While existing investors who want to book listing gains may exit their holdings, investors with a long-term view can hold the stock by keeping a stop loss at Rs 35, she added.
Noida-based GP Eco Solutions India files IPO draft papers with NSE Emerge
GP Eco proposes to utilise Rs 12.45 crore of the issue proceeds to meet the working capital requirements and invest Rs 7.6 crore in its subsidiary, Invergy India to procure plant, machinery and for setting up a new facility.
Mukka Proteins to list tomorrow. What GMP indicates ahead of debut?
The shares of Mukka Proteins will debut on the exchanges on Thursday. Ahead of the listing, the company's shares are trading with a GMP of Rs 35.
Mukka Proteins IPO allotment: Here's how you can check status
Mukka Proteins is finalizing share allotment after a successful IPO. The status can be checked on the BSE or registrar's website. The company's shares are trading with a premium in the unlisted market. It has a leading position in fish meal and oil production, with strong domestic sales and exports to multiple countries.
Mukka Proteins IPO subscribed nearly 137 times on last day. Check GMP and other details
Mukka Proteins IPO GMP: Most analysts have given a subscribe recommendation for Mukka Proteins IPO from a long-term view over fair valuations and a unique business model. The company's shares are trading with a premium of Rs 25 in the unlisted market
RK Swamy IPO opens tomorrow. 10 things to know before subscribing to the issue
The initial public offering (IPO) of RK Swamy will open for subscription on Monday. The issue closes on March 6. Through the public offer, the company plans to raise around Rs 423 crore. Here are 10 things to know about Mukka Proteins IPO before subscribing to the issue.
Mukka Proteins IPO subscribed nearly 5 times so far on Day 2. Check GMP and other details
Most analysts gave a subscribe recommendation for the IPO from a long term perspective over fair valuations and unique business model.
Gopal Snacks IPO price band fixed at Rs 381-401/share; issue to open on March 6
Gopal Snacks IPO Price Band: Gopal Snacks IPO is an offer for sale worth Rs 650 crore. The snackmaker looks to sell shares in the range of Rs 381-401 per share. The public offer will open next week on March 6 and run till March 11.
Purv Flexipack IPO allotment: Here's how you can check status
Purv Flexipack is finalizing IPO share allotment. Investors can check status on Link Intime India's website. Priced at Rs 71, shares trade with a premium of Rs 110. Proceeds will be used for debt repayment and working capital. Holani Consultants is the lead manager.
Exicom Tele Systems IPO subscribed over 129 times on final day. Check GMP, other details
The initial public offer (IPO) of Exicom Tele Systems was subscribed 129 times on Thursday, the final day of the bidding process
Mukka Proteins IPO fully subscribed on strong retail interest. Check GMP and other details
Mukka Proteins IPO received a healthy response from investors on the first day of bidding, with the issue sailing through within hours of opening. The demand was driven by retail investors, followed by NIIs. Most analysts gave a 'subscribe' recommendation, citing fair valuations and a unique business model.
Owais Metal and Mineral Processing IPO allotment: Here's how you can check status
Owais Metal and Mineral Processing IPO allotment: Owais Metal and Mineral Processing to finalize share allotment process today. Investors can check the allotment status on Bigshare Services website. Shares trading at a premium of Rs 120 in the unlisted market. SME IPO subscribed 220 times with revenues of Rs 39.77 crore.
MVK Agro Food Product IPO: Check issue size, price band, GMP and other details
MVK Agro Food Product IPO: The SME IPO of MVK Agro Food Product opens for subscription today to raise about Rs 66 crore. It operates a sugar unit in Nanded, Maharashtra and offers 54.9 lakh shares at Rs 120 apiece, with revenues of Rs 60.12 crore and net profit of Rs 4.3 crore.
GPT Healthcare shares list at 16% premium over IPO price
GPT Healthcare Share Price: GPT Healthcare's IPO debuted with a 16.2% premium. It raised Rs 525 crore for prepayment/repayment of borrowings. The company operates four multispecialty hospitals. Revenue grew at 53.87% CAGR. Three-month total income was Rs 97.63 crore, net profit was Rs 9.98 crore.
Mukka Proteins IPO opens for subscription. Should you bid?
Mukka Proteins IPO opened with a price band of Rs 26-28 per equity share. The company aims to raise Rs 224 crore through the IPO, which closes on March 4. Analysts recommend subscribing due to fair valuations and a unique business model.
Mukka Proteins raises Rs 67 crore from anchor investors ahead of IPO
Anchor investors who participated in the anchor were Neomile Growth Fund, Saint Capital Fund, Zinnia Global Fund PCC, Eminence Global Fund PCC, Craft Emerging Market Fund PCC and Elara India Opportunities Fund.
Mukka Proteins IPO opens tomorrow: 10 things to know before subscribing to the issue
The initial public offering (IPO) of Mukka Proteins will open for subscription on Thursday. The issue closes on March 4. Through the public offer, the company plans to raise around Rs 224 crore. Here are 10 things to know about Mukka Proteins IPO before subscribing to the issue.
Mukka Proteins IPO price band set at Rs 26-28/share. Check lot size and other key details
The issue will be a book-building process where investors will be allowed to make bids for a minimum of 535 shares and in multiples thereafter. Up to 35% of the issue has been reserved for retail investors while non-institutional investors have been allocated 15%.
Will IPO fervor hit new peaks in 2024 after a hectic 2023?
After a hectic 2023, the IPO pipeline remains equally strong in 2024 despite the volatility that comes around with general elections scheduled later this year.
Mukka Proteins gets Sebi nod to float IPO
The company, which had refiled its draft IPO papers with the regulator in June, obtained an observation letter from it on October 30, an update with the Securities and Exchange Board of India (Sebi) showed on Tuesday.
Nifty healthcare index stocks; Staying bullish on select pharma and hospitals
While they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different. We take a look at what analysts are saying about different stocks from each of these segments. Stock Reports Plus, powered by Refinitiv, is a comprehensive research report that evaluates five key components of 4,000+ listed stocks - earnings, fundamentals, relative valuation, risk and price momentum to generate standardized scores.
Mukka Proteins refiles DRHP to raise funds via IPO
Mukka Proteins has submitted a new draft red herring prospectus to the SEBI for an IPO to raise funds. The company, which leads India’s fish protein industry, intends to offer up to eight crore shares, with a face value of Re1, in a fresh issue. At least 35% will be available to retail individual bidders, while up to INR10 crore ($1.3m) will be invested in Mukka’s associate, Ento Proteins Private Limited. More than 50% of the issue will be open to allocation to qualified institutional buyers. The company’s DRHP shows it made INR770.5 crore in revenue in FY22, up 27.6% YoY.
Load More
